LeafNLP Demos
Back to explore

Report #2886155

Received Feb 19, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NE
Recovered
Unknown
Vaccinated
Dec 17, 2025
Onset
Dec 17, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS12A3HYLA

Symptoms (1)

Product preparation issue

Symptom narrative

The diluent was administered only; The diluent was administered only; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 2A3HY, expiry date 26-APR-2027) for prophylaxis. On 17-DEC-2025, the patient received the 1st dose of Shingrix (left deltoid). On 17-DEC-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: The diluent was administered only) and inappropriate dose of vaccine administered (Verbatim: The diluent was administered only). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 19-DEC-2025 The health care professional reported that the employee was trainee and did not mix the medication, only diluent was administered.